Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that its trading window will remain closed for all designated persons and their immediate relatives from 1st January 2026 until 48 hours after the announcement of unaudited financial results for the quarter and nine months ended 31st December 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015. The board meeting date to approve the Q3 FY26 results has not yet been disclosed and will be communicated later.
No direct impact on shareholders — this is a standard regulatory filing restricting insiders from trading ahead of the quarterly results. Investors should watch for the upcoming Q3 FY26 results announcement, which is likely the next catalyst for the stock.